Laina Rosebrock
Contact information
Research groups
Laina Rosebrock
BS, MS, PhD
Research Clinical Psychologist
I received my PhD in clinical psychology from Northwestern University – Feinberg School of Medicine in Chicago, Illinois. I completed my clinical internship and postdoctoral fellowship at the Department of Veterans Affairs (VA) Boston Healthcare System in Boston, Massachusetts, where I worked with veterans from all eras with a range of clinical presentations and diagnoses.
My research and clinical focus is on developing and implementing effective, evidence-based cognitive behavioural therapies for patients with psychosis, anxiety, depression, and PTSD. In particular, I am interested in using virtual reality (VR) to automate the provision of CBT and enable access to effective therapies for many more people.
I have served as a trial coordinator and trial therapist for several RCTs testing VR and face to face cognitive interventions for people with persecutory delusions and agoraphobic avoidance. These projects have included collaborations with multiple NHS Trusts.
I am an HCPC registered Clinical Psychologist.
Recent publications
-
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Journal article
Altunkaya J. et al, (2022), J Med Internet Res, 24
-
A Safe Place to Learn: A Peer Research Qualitative Investigation of Automated Virtual Reality Cognitive Therapy (gameChange).
Journal article
WAITE F. et al, (2022), JMIR Serious Games
-
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
Journal article
Freeman D. et al, (2022), Lancet Psychiatry
-
The Oxford Agoraphobic Avoidance Scale.
Journal article
LAMBE S. et al, (2021), Psychological Medicine
-
Injection fears and COVID-19 vaccine hesitancy.
Journal article
Freeman D. et al, (2021), Psychol Med, 1 - 24